Trials / Completed
CompletedNCT05015322
Comparison of the Effectiveness of the Ultrasound Guided Injections in Patients With Shoulder Impingement Syndrome
Comparison of the Effectiveness of the Ultrasound Guided Subacromial, Acromioclavicular With Subacromial Injection and Suprascapular Nerve Block in Patients With Shoulder Impingement Syndrome ; A Randomized Controlled, Single Blind, Clinical Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 88 (actual)
- Sponsor
- Bursa Yuksek Ihtisas Training and Research Hospital · Other Government
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Shoulder pain, which is the third most common cause of musculoskeletal pain, has different etiologies. Muscle, bone structures and connective tissue pathologies can cause shoulder pain. Impingement syndrome (IS), which can cover many terms such as rotator cuff disorders, tendinitis and tears, is one of the most common pathologies of shoulder pain.
Detailed description
The hypothesis of this study was that injection types including ACJ would increase treatment efficacy.Therefore, this study investigated the six-month follow-up results of patients undergoing SA injection and SSNB and those receiving SA and ACJ injection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bupivacaine and methylprednisolone | 5 mL of 0.25% bupivacaine containing 20 mg methylprednisolone was administered to the subacromial area |
| DRUG | bupivacaine and methylprednisolone | 5 mL of 0.25% bupivacaine containing 20 mg methylprednisolone was administered to the subacromial area for the subacromial+acromioclavicular joint injection. In addition, 2 mL of 20 mg methylprednisolone and the same concentration of local anaesthetic were injected into the acromioclavicular joint |
| DRUG | bupivacaine and methylprednisolone | suprascapular nerve block was administered with a mixture of 10 mL of 0.25% bupivacaine and 40 mg methylprednisolone |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2021-01-01
- Completion
- 2021-01-01
- First posted
- 2021-08-20
- Last updated
- 2021-08-20
Source: ClinicalTrials.gov record NCT05015322. Inclusion in this directory is not an endorsement.